Quick Answer
Akso Health Group reported Total Revenue of $14.78 million for fiscal year 2025.
Akso Health Group — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $14.78M +512.1% |
$2.41M -81.7% |
$13.18M +119.7% |
$6.00M +241.9% |
$1.75M -74.6% |
$6.91M +87.1% |
| Revenue (ASC 606) | — | — | — | $6.31M +259.6% |
$1.75M -74.6% |
$6.91M +87.1% |
| Net Income | -$134.98M -1327.0% |
-$9.46M -595.5% |
-$1.36M +91.9% |
-$16.85M +51.6% |
-$34.83M +51.1% |
-$71.20M -1386.9% |
| Diluted EPS | -$0.16 -128.6% |
-$0.07 -250.0% |
-$0.02 +92.9% |
-$0.28 +60.6% |
-$0.71 +51.4% |
-$1.46 -1560.0% |
| Total Assets | $214.95M +51.4% |
$142.02M +594.1% |
$20.46M -67.4% |
$62.81M +98.2% |
$31.69M -60.6% |
$80.48M -53.6% |
| Cash and Equivalents | $176.23M +106.9% |
$85.17M +974.8% |
$7.92M -57.0% |
$18.43M +21.8% |
$15.13M +126.9% |
$6.67M -88.4% |
| Stockholders Equity | $199.12M +43.9% |
$138.37M +1485.8% |
$8.73M -29.0% |
$12.28M -28.9% |
$17.27M -64.1% |
$48.10M -62.0% |
| Operating Income | -$166.30M -1825.3% |
-$8.64M +39.5% |
-$14.27M -337.6% |
-$3.26M +23.1% |
-$4.24M +91.2% |
-$48.11M -569.1% |
| Gross Profit | -$281.5K -330.5% |
$122.1K -90.4% |
$1.27M +109.7% |
$605.1K -65.5% |
$1.75M -74.6% |
$6.91M |
| Shares Outstanding | 1.66B +278.7% |
437.17M +537.3% |
68.60M +0.0% |
68.60M +40.4% |
48.85M +0.1% |
48.82M -0.8% |
- Akso Health Group reported Total Revenue of $14.78 million for fiscal year 2025.
- Akso Health Group showed an increase of +512.1% in Total Revenue compared to the prior fiscal year.
- Akso Health Group reported Revenue (ASC 606) of $6.31 million for fiscal year 2022.
- Akso Health Group showed an increase of +259.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Akso Health Group reported Net Income of -$134.98 million for fiscal year 2025.
- Akso Health Group showed a decrease of -1327.0% in Net Income compared to the prior fiscal year.
- Akso Health Group reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
- Akso Health Group showed a decrease of -128.6% in Diluted EPS compared to the prior fiscal year.
- Akso Health Group reported Total Assets of $214.95 million for fiscal year 2025.
- Akso Health Group showed an increase of +51.4% in Total Assets compared to the prior fiscal year.
- Akso Health Group reported Cash and Equivalents of $176.23 million for fiscal year 2025.
- Akso Health Group showed an increase of +106.9% in Cash and Equivalents compared to the prior fiscal year.
- Akso Health Group reported Stockholders Equity of $199.12 million for fiscal year 2025.
- Akso Health Group showed an increase of +43.9% in Stockholders Equity compared to the prior fiscal year.
- Akso Health Group reported Operating Income of -$166.30 million for fiscal year 2025.
- Akso Health Group showed a decrease of -1825.3% in Operating Income compared to the prior fiscal year.
- Akso Health Group reported Gross Profit of -$281.5 thousand for fiscal year 2025.
- Akso Health Group showed a decrease of -330.5% in Gross Profit compared to the prior fiscal year.
- Akso Health Group reported Shares Outstanding of 1.66 billion shares for fiscal year 2025.
- Akso Health Group showed an increase of +278.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: